These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6769608)

  • 1. Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
    Armstrong PW; Armstrong JA; Marks GS
    Circulation; 1980 Jul; 62(1):160-6. PubMed ID: 6769608
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
    Pitt WA; Friedman RG; Gross SA; Glassman J; Keating EC; Mazur JH
    Angiology; 1982 May; 33(5):294-301. PubMed ID: 6805373
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
    Elkayam U; Roth A; Henriquez B; Weber L; Tonnemacher D; Rahimtoola SH
    Am J Cardiol; 1985 Sep; 56(8):555-9. PubMed ID: 3929585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin.
    Rajfer SI; Demma FJ; Goldberg LI
    Am J Cardiol; 1984 Jul; 54(1):120-5. PubMed ID: 6430054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure.
    Armstrong PW; Armstrong JA; Marks GS
    Am J Cardiol; 1980 Oct; 46(4):670-6. PubMed ID: 6774604
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the hemodynamic effects of intravenous Trinitrine. Applications to the vasodilator treatment of heart failure, myocardial infarct, and mitral insufficiency].
    Baligadoo S; Ingrand JC; Derrida JP; Savier CH; Chiche P
    Coeur Med Interne; 1978; 17(2):231-42. PubMed ID: 95918
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure.
    Kamijo T; Tomaru T; Miwa AY; Nakamura F; Kido H; Sugimoto T; Uchida Y
    Jpn J Pharmacol; 1994 Jul; 65(3):223-31. PubMed ID: 7799523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of oxprenolol alone and combined with nitroglycerin in patients with ischemic heart disease.
    Lecerof H; Malmborg RO
    Acta Med Scand; 1972 Dec; 192(6):499-506. PubMed ID: 4629694
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic effects of nitroglycerin ointment in congestive heart failure.
    Taylor WR; Forrester JS; Magnusson P; Takano T; Chatterjee K; Swan HJ
    Am J Cardiol; 1976 Oct; 38(4):469-73. PubMed ID: 823808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M; Lee WH
    Am J Cardiol; 1986 Feb; 57(4):260-7. PubMed ID: 3080861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of intravenous nitroglycerin in chronic cardiac failure].
    Bory M
    Nouv Presse Med; 1979 Jan; 8(4):279-82. PubMed ID: 122022
    [No Abstract]   [Full Text] [Related]  

  • 12. Radionuclide angiography: noninvasive assessment of hemodynamic changes after administration of nitroglycerin.
    Ritchie JL; Sorensen S; Kennedy JW; Hamilton GW
    Am J Cardiol; 1979 Feb; 43(2):278-84. PubMed ID: 104610
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.
    Jordan RA; Seith L; Henry DA; Wilen MM; Franciosa JA
    Circulation; 1985 May; 71(5):980-6. PubMed ID: 3921279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained hemodynamic effects with therapeutic doses of intravenous nitroglycerin in congestive heart failure.
    Natarajan D; Khurana TR; Karhade V; Nigam PD
    Am J Cardiol; 1988 Aug; 62(4):319-21. PubMed ID: 3135741
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic effects of nitrate derivatives (trinitrine and isosorbide dinitrate)].
    Baligadoo S; Chiche P
    Coeur Med Interne; 1979; 18(2):271-82. PubMed ID: 114352
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous nitroglycerin.
    Flaherty JT
    Johns Hopkins Med J; 1982 Jul; 151(1):36-40. PubMed ID: 6806519
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic resistance to intravenous nitroglycerin in severe congestive heart failure and restored response after diuresis.
    Varriale P; David WJ; Chryssos BE
    Am J Cardiol; 1991 Nov; 68(13):1400-2. PubMed ID: 1951133
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction.
    Dikshit K; Vyden JK; Forrester JS; Chatterjee K; Prakash R; Swan HJ
    N Engl J Med; 1973 May; 288(21):1087-90. PubMed ID: 4697939
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic effects of diuresis by ethacrynic acid in normal subjects and in patients with congestive heart failure.
    Ramírez A; Abelmann WH
    Arch Intern Med; 1968 Apr; 121(4):320-7. PubMed ID: 5645703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.